These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35389604)

  • 1. [Cardiovascular complications associated with acromegaly. A state-of-the-art].
    Concepción-Zavaleta M; Muñoz-Moreno J; Quispe-Flores M; Rafael-Robles L; Lobato-Jeri C; Ramos-Yataco A; Concepción-Urteaga L; Paz-Ibarra J
    Arch Cardiol Mex; 2022 Oct; 92(4):513-521. PubMed ID: 35389604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heart failure as a manifestation of acromegaly].
    Ságová I; Dragula M; Kantárová D; Vaňuga A; Vaňuga P
    Vnitr Lek; 2020; 66(4):82-86. PubMed ID: 32972190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acromegaly and it's cardiovascular implications].
    Cadena-Obando DA; Remba-Shapiro I; Abreu-Rosario CG; Mercado M
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):73-80. PubMed ID: 33667046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.
    Ramos-Leví AM; Marazuela M
    Endocrine; 2017 Feb; 55(2):346-359. PubMed ID: 28042644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular disturbances in acromegaly].
    Fedrizzi D; Czepielewski MA
    Arq Bras Endocrinol Metabol; 2008 Dec; 52(9):1416-29. PubMed ID: 19197449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acromegaly and the cardiovascular system.
    Lombardi G; Galdiero M; Auriemma RS; Pivonello R; Colao A
    Neuroendocrinology; 2006; 83(3-4):211-7. PubMed ID: 17047385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of juvenile acromegaly that was initially diagnosed as severe congestive heart failure from acromegaly-induced dilated cardiomyopathy.
    Sue M; Yoshihara A; Okubo Y; Ishikawa M; Ando Y; Hiroi N; Shibuya K; Yoshino G
    Intern Med; 2010; 49(19):2117-21. PubMed ID: 20930439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac abnormalities in acromegaly. Pathophysiology and implications for management.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Treat Endocrinol; 2004; 3(5):309-18. PubMed ID: 15330678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Disease in Acromegaly.
    Sharma MD; Nguyen AV; Brown S; Robbins RJ
    Methodist Debakey Cardiovasc J; 2017; 13(2):64-67. PubMed ID: 28740584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acromegalic cardiomyopathy: a neglected cause of cardiomyopathy.
    Bonora T; Rigamonti E; Capoferri M; De Perna ML
    Clin Ter; 2022 Feb; 173(1):31-34. PubMed ID: 35147643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular complications in acromegaly.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Minerva Endocrinol; 2004 Sep; 29(3):77-88. PubMed ID: 15282442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac effect of thyrotoxicosis in acromegaly.
    Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep apnea and cardiovascular complications of the acromegaly. Response to the medical treatment.
    García-Álvarez M; Climent V
    Minerva Endocrinol; 2019 Jun; 44(2):159-168. PubMed ID: 30482010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acromegalic Cardiomyopathy: An Overview of Risk Factors, Clinical Manifestations, and Therapeutic Options.
    Goldberg MD; Vadera N; Yandrapalli S; Frishman WH
    Cardiol Rev; 2018; 26(6):307-311. PubMed ID: 29794808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular complications of acromegaly.
    Kamenický P; Maione L; Chanson P
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):206-209. PubMed ID: 33168155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case and review of acromegaly-induced cardiomyopathy and the relationship between growth hormone and heart failure: cause or cure or neither or both?
    Schwarz ER; Jammula P; Gupta R; Rosanio S
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):232-44. PubMed ID: 17220469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.